BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 11981559)

  • 1. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo.
    Neildez-Nguyen TM; Wajcman H; Marden MC; Bensidhoum M; Moncollin V; Giarratana MC; Kobari L; Thierry D; Douay L
    Nat Biotechnol; 2002 May; 20(5):467-72. PubMed ID: 11981559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells.
    Giarratana MC; Kobari L; Lapillonne H; Chalmers D; Kiger L; Cynober T; Marden MC; Wajcman H; Douay L
    Nat Biotechnol; 2005 Jan; 23(1):69-74. PubMed ID: 15619619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
    Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
    Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions.
    Gammaitoni L; Lucchi S; Bruno S; Tesio M; Gunetti M; Pignochino Y; Migliardi G; Lazzari L; Aglietta M; Rebulla P; Piacibello W
    Stem Cells; 2006 May; 24(5):1201-12. PubMed ID: 16410386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plant mannose-binding lectin NTL preserves cord blood haematopoietic stem/progenitor cells in long-term culture and enhances their ex vivo expansion.
    Li K; Ooi VE; Chuen CK; Lam AC; Ooi LS; Zhang XB; Tsang KS; Chiu LC; Chan KY; Li CK; Fok TF; Yuen PM; Ng PC
    Br J Haematol; 2008 Jan; 140(1):90-8. PubMed ID: 17908183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess.
    Madlambayan GJ; Rogers I; Purpura KA; Ito C; Yu M; Kirouac D; Casper RF; Zandstra PW
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1020-30. PubMed ID: 17084368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro generation of mature and functional human red blood cells: a model with multidisciplinary perspectives].
    Douay L; Giarratana MC
    Bull Acad Natl Med; 2005 May; 189(5):903-13; discussion 914-5. PubMed ID: 16433462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions.
    Gunetti M; Ferrero I; Rustichelli D; Berger M; Gammaitoni L; Timeus F; Piacibello W; Aglietta M; Fagioli F
    Exp Hematol; 2008 Feb; 36(2):235-43. PubMed ID: 18206730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo generation of human red blood cells: a new advance in stem cell engineering.
    Douay L; Giarratana MC
    Methods Mol Biol; 2009; 482():127-40. PubMed ID: 19089353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of growth factor conditions that reduce ex vivo cord blood progenitor expansion but do not alter human repopulating cell function in vivo.
    Levac K; Karanu F; Bhatia M
    Haematologica; 2005 Feb; 90(2):166-72. PubMed ID: 15710567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small peptide analogue of SDF-1alpha supports survival of cord blood CD34+ cells in synergy with other cytokines and enhances their ex vivo expansion and engraftment into nonobese diabetic/severe combined immunodeficient mice.
    Li K; Chuen CK; Lee SM; Law P; Fok TF; Ng PC; Li CK; Wong D; Merzouk A; Salari H; Gu GJ; Yuen PM
    Stem Cells; 2006 Jan; 24(1):55-64. PubMed ID: 16123381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells.
    da Silva CL; Gonçalves R; Crapnell KB; Cabral JM; Zanjani ED; Almeida-Porada G
    Exp Hematol; 2005 Jul; 33(7):828-35. PubMed ID: 15963859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD/SCID mice.
    Nitsche A; Junghahn I; Thulke S; Aumann J; Radonić A; Fichtner I; Siegert W
    Stem Cells; 2003; 21(2):236-44. PubMed ID: 12634420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells.
    Baek EJ; Kim HS; Kim S; Jin H; Choi TY; Kim HO
    Transfusion; 2008 Oct; 48(10):2235-45. PubMed ID: 18673341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale production of embryonic red blood cells from human embryonic stem cells.
    Olivier EN; Qiu C; Velho M; Hirsch RE; Bouhassira EE
    Exp Hematol; 2006 Dec; 34(12):1635-42. PubMed ID: 17157159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.
    Fei XM; Wu YJ; Chang Z; Miao KR; Tang YH; Zhou XY; Wang LX; Pan QQ; Wang CY
    Cytotherapy; 2007; 9(4):338-47. PubMed ID: 17573609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of ex vivo expansion and engraftment in NOD-SCID mice of umbilical cord blood CD34+ cells using the DIDECO "Pluricell System".
    Astori G; Adami V; Mambrini G; Bigi L; Cilli M; Facchini A; Falasca E; Malangone W; Panzani I; Degrassi A
    Bone Marrow Transplant; 2005 Jun; 35(11):1101-6. PubMed ID: 15821764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [From control of hematopoiesis to cellular therapy: the perspectives for transfusion].
    Douay L
    Ann Biol Clin (Paris); 2003; 61(3):259-67. PubMed ID: 12805002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.